Head and neck cancers, Laryngeal cancer, Mouth and oropharyngeal cancer, Nasal and paranasal sinus cancer , Nasopharyngeal cancer, Pharyngeal cancer
Results
Phase 2
This trial looked at buparlisib for squamous cell cancer of the head and neck. This included people with cancer that had started in the mouth, the throat or the voice box (larynx).
It was open for people to join between 2013 and 2015, and the research team published results in 2017.
Recruitment start: 5 November 2013
Recruitment end: 5 May 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Martin Forster
NIHR Clinical Research Network: Cancer
Novartis
Last reviewed: 2 April 2020
CRUK internal database number: 11871
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
